Peter Palframan

Peter Palframan

Director/Board Member at CONQUEST RESOURCES LIMITED

Net worth: 69 625 $ as of 2026-06-29

Consumer Services
Technology Services
Non-Energy Minerals

Profile

Peter Clive Palframan currently works at Conquest Resources Ltd., as Independent Director from 2006, ZoomerMedia Ltd., as Independent Non-Executive Director from 2009, and Darwin Cx, Inc., as Director.
Mr. Palframan also formerly worked at Magic Lantern Media, Inc., as Chief Executive Officer from 2009 to 2016, Conquest Resources Ltd., as Director in 2002, Cynapsus Therapeutics, Inc., as Director from 2006 to 2010, Jite Technologies, Inc., as Chief Financial Officer, Learning & Skills Television of Alberta Ltd., as Vice President-Finance & Operations, CHUM Television, as Vice President-Finance & Administration, Deloitte & Touche, Inc., as Accountant, and VisionTV (Canada), as Vice President-Finance from 1987 to 1995.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
2026-04-20 1,420,909 ( 0.92% ) 69 625 $ 2026-06-29

Peter Palframan active positions

CompaniesPositionStart
CONQUEST RESOURCES LIMITED Director/Board Member 2006-05-31
ZOOMERMEDIA Director/Board Member 2009-07-19
Director/Board Member -

Former positions of Peter Palframan

CompaniesPositionEnd
Chief Executive Officer 2016-03-31
CYNAPSUS THERAPEUTICS INC Director/Board Member 2010-01-10
Director of Finance/CFO -
CONQUEST RESOURCES LIMITED Director/Board Member 2002-04-30
Director of Finance/CFO 1994-12-31
See the detail of Peter Palframan's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

33

1st degree connections

10

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies10

Non-Energy Minerals

Health Technology

Electronic Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Consumer Services

Technology Services

Technology Services

  1. Stock Market
  2. Insiders
  3. Peter Palframan